NUTX (Nutex Health) Other Long-Term Liabilities: $-0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NUTX Nutex Health Inc NUTX
75 GF Score
Price $191.64
GF Value $82.60
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Nutex Health Other Long-Term Liabilities?

Nutex Health NUTX -1.17% 75 Other Long-Term Liabilities is $-0.0 Mil as of Jun. 2026. GuruFocus rates NUTX with a GF Score™ of 75/100 and a GF Value™ of $82.60 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Nutex Health's other long-term liabilities for the quarter that ended in Jun. 2026 was $-0.0 Mil.

Nutex Health's quarterly other long-term liabilities declined from Dec. 2025 ($-0.0 Mil) to Mar. 2026 ($-0.0 Mil) but then increased from Mar. 2026 ($-0.0 Mil) to Jun. 2026 ($-0.0 Mil).

Nutex Health's annual other long-term liabilities increased from Dec. 2023 ($-0.0 Mil) to Dec. 2024 ($0.0 Mil) but then declined from Dec. 2024 ($0.0 Mil) to Dec. 2025 ($-0.0 Mil).

Nutex Health Other Long-Term Liabilities Related Terms

Nutex Health Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Nutex Health's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nutex Health Other Long-Term Liabilities Chart

Nutex Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Long-Term Liabilities
Get a 7-Day Free Trial 0.00 0.00 -0.00 0.00 -0.00

Nutex Health Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.00 -0.00 -0.00 -0.00
NUTX
75GF Score
Nutex Health Inc NUTX
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nutex Health Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of $-0.0 Mil mean?
Nutex Health (NUTX) has a Other Long-Term Liabilities of $-0.0 Mil as of Jun. 2026. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Nutex Health and its competitors.
Is Nutex Health's Other Long-Term Liabilities too high?
Nutex Health's current Other Long-Term Liabilities is $-0.0 Mil. Overall, Nutex Health has a GF Score™ of 75/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nutex Health's Other Long-Term Liabilities compare to USPH and AMN?
Nutex Health's Other Long-Term Liabilities of $-0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Healthcare Providers & Services company?
A good Other Long-Term Liabilities depends on the Healthcare Providers & Services industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Nutex Health and its competitors. Nutex Health's current Other Long-Term Liabilities is $-0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nutex Health stock overvalued right now?
Based on GuruFocus' analysis, Nutex Health (NUTX) is currently considered Significantly Overvalued. The stock's GF Value™ is $82.60, compared to a current price of $191.64 — trading 132% above its estimated fair value. The current Other Long-Term Liabilities is $-0.0 Mil. Nutex Health's overall GF Score™ is 75/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Nutex Health (NUTX), the current Other Long-Term Liabilities is $-0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nutex Health (NUTX) Overvalued in 2026?

Based on GuruFocus' analysis, Nutex Health stock appears to be overvalued. The current stock price of $191.64 is trading 132% above its estimated GF Value™ of $82.60. GuruFocus considers Nutex Health to be Significantly Overvalued.

Key valuation signals for NUTX:

  • Other Long-Term Liabilities: $-0.0 Mil
  • GF Value™: $82.60 vs. price of $191.64 (132% above fair value)
  • GF Score™: 75/100 with 6 warning signs

No single metric tells the full story. See the NUTX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nutex Health Business Description

Other Exchanges 5LF:Germany
Address 1776 Yorktown Street, Suite 700, Houston, TX, USA, 77056
Nutex Health Inc is a physician-led, healthcare services and operations company with various hospital facilities in the U.S. states (hospital division), and a primary care-centric, risk-bearing population health management division. The company has three segments: the hospital division, the PHM division, and the real estate division. The hospital division implements and operates health care models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management (PHM) division owns and operates provider networks such as independent physician associations (IPAs). The Real Estate Entities own the land and hospital buildings which are leased to its hospital entities. The majority of the revenue is derived from the Hospital division.
75GF Score

Get the complete analysis for NUTX

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$191.64
Price
$82.60
GF Value